|
1
|
Khetan P, Boffetta P, Luce D, Stucker I,
Curado MP, Menezes A, Wunsch-Filho V, Ahrens W, Lagiou P, Serraino
D, et al: Occupations and the risk of head and neck cancer: A
pooled analysis of the international head and neck cancer
epidemiology (INHANCE) consortium. J Occup Environ Med. 61:397–404.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Moro JDS, Maroneze MC, Ardenghi TM, Barin
LM and Danesi CC: Oral and oropharyngeal cancer: Epidemiology and
survival analysis. Einstein (Sao Paulo). 16(eAO4248)2018.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
3
|
Hashim D and Boffetta P: Head and neck
cancers. In: Occupational Cancers. Anttila S and Boffetta P (eds).
Springer, Cham, Switzerland, pp57-105, 2020.
|
|
4
|
Cramer JD, Burtness B, Le QT and Ferris
RL: The changing therapeutic landscape of head and neck cancer. Nat
Rev Clin Oncol. 16:669–683. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mankowski NL and Bordoni B: Anatomy, head
and neck, nasopharynx. [Updated 2021 Feb. 7]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; Available
from: https://www.ncbi.nlm.nih.gov/books/NBK557635. Accessed
March 13, 2021.
|
|
6
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shah AB, Zulfiqar H and Nagalli S:
Nasopharyngeal carcinoma. [Updated 2020 Sep. 8]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing. Available
from: https://www.ncbi.nlm.nih.gov/books/NBK554588. Accessed
March 13, 2021.
|
|
8
|
Niaz K, Maqbool F, Khan F, Bahadar H,
Ismail Hassan F and Abdollahi M: Smokeless tobacco (paan and
gutkha) consumption, prevalence, and contribution to oral cancer.
Epidemiol Health. 39(e2017009)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pichardo G: Nasopharyngeal cancer.
[20.01.2020]. In: WebMD.com [Internet]. Available from:
https://www.webmd.com/cancer/nasopharyngeal-cancer.
Accessed March 13, 2020.
|
|
10
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nwabudike LC and Tatu AL: Reply to Happle
R et al. Koebner's sheep in Wolf's clothing: Does the
isotopic response exists as a distinct phenomenon? J Eur Acad
Dermatol Venereol. 32:e336–e337. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xing B, Qiao XF, Qiu YH and Li X: TMPO-AS1
regulates the aggressiveness-associated traits of nasopharyngeal
carcinoma cells through sponging miR-320a. Cancer Manag Res.
13:415–425. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Manfredi R, Sabbatani S, Gianelli U and
Marinacci G: Epstein-Barr virus associated nasopharyngeal carcinoma
and local polymorphic B-cell lymphoproliferative disorder in a
patient with HIV disease. J Int Assoc Physicians AIDS Care (Chic).
6:255–259. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hald J and Larsen PL: Nasopharyngeal
carcinoma in an HIV-positive patient causing severe morbidity and
early death. J Laryngol Otol. 107:149–150. 1993.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Draganescu M, Baroiu L, Iancu A, Dumitru
C, Radaschin D, Polea ED, Bobeica C, Tatu AL, Niculet E and Fekete
GL: Perspectives on skin disorder diagnosis among people living
with HIV in southeastern Romania. Exp Ther Med.
21(97)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tsao SW, Tsang CM and Lo KW: Epstein-Barr
virus infection and nasopharyngeal carcinoma. Philos Trans R Soc
Lond B Biol Sci. 372(20160270)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nakanishi Y, Wakisaka N, Kondo S, Endo K,
Sugimoto H, Hatano M, Ueno T, Ishikawa K and Yoshizaki T:
Progression of understanding for the role of Epstein-Barr virus and
management of nasopharyngeal carcinoma. Cancer Metastasis Rev.
36:435–447. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kieser A and Sterz KR: The latent membrane
protein 1 (LMP1). Curr Top Microbiol Immunol. 391:119–149.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nwabudike LC and Tatu AL: Reply to
Gambichler T et al: Altered epigenetic pathways and cell
cycle dysregulation in healthy appearing skin of patients with
koebnerized squamous cell carcinomas following skin surgery. J Eur
Acad Dermatol Venereol. 33:e3–e4. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sun W, Liu DB, Li WW, Zhang LL, Long GX,
Wang JF, Mei Q and Hu GQ: Interleukin-6 promotes the migration and
invasion of nasopharyngeal carcinoma cell lines and upregulates the
expression of MMP-2 and MMP-9. Int J Oncol. 44:1551–1560.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Niculet E, Chioncel V, Elisei AM, Miulescu
M, Buzia OD, Nwabudike LC, Craescu M, Draganescu M, Bujoreanu F,
Marinescu E, et al: Multifactorial expression of IL-6 with update
on COVID-19 and the therapeutic strategies of its blockade
(Review). Exp Ther Med. 21(263)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine factors and head and neck squamous cell
carcinoma: An affair to remember. Dis Markers.
2018(9787831)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chow KC, Chiou SH, Ho SP, Tsai MH, Chen
CL, Wang LS and Chi KH: The elevated serum interleukin-6 correlates
with the increased serum butyrate level in patients with
nasopharyngeal carcinoma. Oncol Rep. 10:813–819. 2003.PubMed/NCBI
|
|
24
|
Low JS, Chua ET, Gao F and Wee JT:
Stereotactic radiosurgery plus intracavitary irradiation in the
salvage of nasopharyngeal carcinoma. Head Neck. 28:321–329.
2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liao W, Tian M and Chen N: Characteristic
and novel therapeutic strategies of nasopharyngeal carcinoma with
synchronous metastasis. Cancer Manag Res. 11:8431–8442.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Deng F and Gaillard F: Nasopharyngeal
cancer (staging). Available at: https://radiopaedia.org/articles/nasopharyngeal-cancer-staging?lang=us.
Accessed March 14, 2020.
|
|
27
|
Guo R, Mao YP, Tang LL, Chen L, Sun Y and
Ma J: The evolution of nasopharyngeal carcinoma staging. Br J
Radiol. 92(20190244)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Song C and Yang S: A meta-analysis on the
EBV DNA and VCA-IgA in diagnosis of nasopharyngeal carcinoma. Pak J
Med Sci. 29:885–890. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tsai ST, Jin YT, Mann RB and Ambinder RF:
Epstein-Barr virus detection in nasopharyngeal tissues of patients
with suspected nasopharyngeal carcinoma. Cancer. 82:1449–1453.
1998.PubMed/NCBI
|
|
30
|
Lam WKJ and Chan JYK: Recent advances in
the management of nasopharyngeal carcinoma. F1000Res 7 (F1000
Faculty Rev): 1829, 2018.
|
|
31
|
Hildesheim A and Wang CP: Genetic
predisposition factors and nasopharyngeal carcinoma risk: A review
of epidemiological association studies, 2000-2011: Rosetta stone
for NPC: Genetics, viral infection, and other environmental
factors. Semin Cancer Biol. 22:107–116. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ma Z, Wang W, Zhang Y, Yao M, Ying L and
Zhu L: Inhibitory effect of simvastatin in nasopharyngeal carcinoma
cells. Exp Ther Med. 17:4477–4484. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nwabudike LC, Elisei AM, Buzia OD,
Miulescu M and Tatu AL: Statins. A review on structural
perspectives, adverse reactions and relations with non-melanoma
skin cancer. Rev Chim (Bucharest). 69:2557–2562. 2018.
|
|
34
|
Xiao X, Zhang Z, Chang ET, Liu Z, Liu Q,
Cai Y, Chen G, Huang QH, Xie SH, Cao SM, et al: Medical history,
medication use, and risk of nasopharyngeal carcinoma. Am J
Epidemiol. 187:2117–2125. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Pottegård A, Hallas J, Olesen M, Svendsen
MT, Habel LA, Friedman GD and Friis S: Hydrochlorothiazide use is
strongly associated with risk of lip cancer. J Intern Med.
282:322–331. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kim MS, Han KD and Kwon SY: Pre-diagnostic
beta-blocker use and head- and neck cancer risk: A nationwide
population-based case-control study. Medicine (Baltimore).
98(e16047)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tatu AL, Elisei AM, Chioncel V, Miulescu M
and Nwabudike LC: Immunologic adverse reactions of β-blockers and
the skin. Exp Ther Med. 18:955–959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wolter NE, Wolter JK, Enepekides DJ and
Irwin MS: Propranolol as a novel adjunctive treatment for head and
neck squamous cell carcinoma. J Otolaryngol Head Neck Surg.
41:334–344. 2012.PubMed/NCBI
|
|
39
|
Zhang L, Mai HM, Zheng J, Zheng JW, Wang
YA, Qin ZP and Li KL: Propranolol inhibits angiogenesis via
down-regulating the expression of vascular endothelial growth
factor in hemangioma derived stem cell. Int J Clin Exp Pathol.
7:48–55. 2013.PubMed/NCBI
|
|
40
|
Leezenberg JA, Wesseling H and Kroon AM:
Possible cytostatic action of tetracyclines in the treatment of
tumors of the nasopharynx and larynx. Eur J Clin Pharmacol.
16:237–241. 1979.
|
|
41
|
Nwabudike LC and Tatu AL: Response to
-chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e159)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ferris RL and Koch WM: Connective tissue
disease coincident with nasopharyngeal carcinoma: Two sporadic
cases in a Western population. Arch Otolaryngol Head Neck Surg.
129:101–105. 2003.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tatu AL and Ionescu MA: Multiple
autoimmune syndrome type 3-thyroiditis, vitiligo and alopecia
areata. Acta Endocrinol (Buchar). 13:124–125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Earar K, Sirbu I, Onisor C and Luca E:
Oral rehabilitation on implants and introduction of pathogenic
mechanisms in relation to oral implants-sugar diabetes. Rev Chim.
70:3750–3752. 2019.
|
|
45
|
Peng XS, Xie GF, Qiu WZ, Tian YH, Zhang WJ
and Cao KJ: Type 2 diabetic mellitus is a risk factor for
nasopharyngeal carcinoma: A 1:2 matched case-control study. PLoS
One. 11(e0165131)2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen AM, Yang CC, Marsano J, Liu T and
Purdy JA: Intensity-modulated radiotherapy for nasopharyngeal
carcinoma: Improvement of the therapeutic ratio with helical
tomotherapy vs segmental multileaf collimator-based techniques. Br
J Radiol. 85:e537–e543. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lee N, Hoffman R, Phillips TL, Xia P,
Quivey JM, Weinberg V and Hsu IC: Managing nasopharyngeal carcinoma
with intracavitary brachytherapy: One institution's 45-year
experience. Brachytherapy. 1:74–82. 2002.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Teo P, Leung S, Lee W and Zee B:
Intracavitary brachytherapy significantly enhances local control of
early T-stage nasopharyngeal carcinoma: The existence of a
dose-tumor-control relationship above conventional tumoricidal
dose. Int J Radiat Oncol Biol Phys. 46:445–458. 2000.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Cheah SK, Lau FN, Yusof MM and Phua VC:
Treatment outcome with brachytherapy for recurrent nasopharyngeal
carcinoma. Asian Pac J Cancer Prev. 14:6513–6518. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Castelli J, Simon A, Lafond C, Perichon N,
Rigaud B, Chajon E, De Bari B, Ozsahin M, Bourhis J and de
Crevoisier R: Adaptive radiotherapy for head and neck cancer. Acta
Oncol. 57:1284–1292. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zhang Y, Sun Y and Ma J: Induction
gemcitabine and cisplatin in locoregionally advanced nasopharyngeal
carcinoma. Cancer Commun (Lond). 25(39)2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lee VH, Lam KO, Chang AT, Lam TC, Chiang
CL, So TH, Choi CW and Lee AW: Management of nasopharyngeal
carcinoma: Is adjuvant therapy needed? J Oncol Pract. 14:594–602.
2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sindhu SK and Bauman JE: Current concepts
in chemotherapy for head and neck cancer. Oral Maxillofac Surg Clin
North Am. 31:145–154. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Tsang RK and Wei WI: Salvage surgery for
nasopharyngeal cancer. World J Otorhinolaryngol Head Neck Surg.
1:34–43. 2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Kam MK, Teo PM, Chau RM, Cheung KY, Choi
PH, Kwan WH, Leung SF, Zee B and Chan AT: Treatment of
nasopharyngeal carcinoma with intensity-modulated radiotherapy: The
Hong Kong experience. Int J Radiat Oncol Biol Phys. 60:1440–1450.
2004.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Stanciu AE, Zamfir-Chiru-Anton A, Stanciu
MM, Stoian AP, Jinga V, Nitipir C, Bucur A, Pituru TS, Arsene AL,
Dragoi CM, et al: Clinical significance of serum melatonin in
predicting the severity of oral squamous cell carcinoma. Oncol
Lett. 19:1537–1543. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Kaidar-Person O, Gil Z and Billan S:
Precision medicine in head and neck cancer. Drug Resist Updat.
40:13–16. 2018.PubMed/NCBI View Article : Google Scholar
|
